Edward T. Mathers - Jun 21, 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Stock symbol
RYTM
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
4
Date filed
6/25/2024, 04:38 PM
Previous filing
Jun 20, 2024
Next filing
Jul 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +3K 3K Jun 21, 2024 Direct F1
holding RYTM Common Stock 5.77K Jun 21, 2024 See Note 2 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -3K -100% $0.00* 0 Jun 21, 2024 Common Stock 3K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The Reporting Person is the trustee of the Edward Timothy Mathers Revocable Trust (the "Mathers Trust"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.
F3 The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date.